Drug
Vegf Trap Eye
Vegf Trap Eye: highest development phase Phase 3, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| VEGF Trap-Eye 2.0mg NCT00943072 | Phase 3 | Macular Edema Secondary to Central Retinal Vein Occlusion |
Latest
No recent events.
Follow Vegf Trap Eye on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.